Pharma, Medical Groups Rebut Motion to Toss Drug Pricing Suit

Infusion therapy providers would be harmed if a federal judge dismisses a lawsuit challenging Medicare’s new drug price negotiation program, attorneys for a coalition of trade associations wrote in a filing Monday.

The Inflation Reduction Act’s drug pricing provisions will result in lower Part D reimbursements to centers administering medicines subject to Medicare negotiations, attorneys representing the National Infusion Center Association said. NICA is joined in its lawsuit by drug industry group the Pharmaceutical Research and Manufacturers of America, as well as the Global Colon Cancer Association.

The groups have demonstrated they will suffer an immediate and direct injury ...